Successful accreditation of our AFORCE-1 study by the Colorectal Cancer Study Board of the German Cancer Society
Successful accreditation of our AFORCE-1 study by the German Cancer Society's Colorectal Cancer Study Board
We are pleased for our customer about the positive evaluation of the AFORCE-1 study by the German Cancer Society's Colorectal Cancer Study Board! Since 05.04.2024, the study on early cancer detection using a new blood test has been listed in the StudyBox under registration number ST-U178. The StudyBox is an internet-based platform that is currently being implemented as a pilot for colorectal cancer centers. Our study thus meets the criteria for recognition of the study within the certification system and is thus becoming more attractive for our test centers in the Berlin area.
Demonstrate the medical benefits of your product
With our many years of experience and expertise, we offer effective solutions to show the medical benefits of your product.
From conception to implementation of preclinical and clinical studies, we support you with tailor-made services.
Find out how MEDIACC can help you get your products refunded.